Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study
Atrial Fibrillation Friday, July 25th, 2014Heartrhythmjournal: June 10, 2014
The Atrial Fibrillation Follow-up Investigation of Rhythm Management trial showed that digoxin was associated with increased mortality in patients with atrial fibrillation.
Objectives
To assess the association of digoxin with cardiovascular (CV) morbidity and mortality in patients with permanent atrial fibrillation enrolled in the Dutch Rate Control Efficacy in Permanent AF: A Comparison Between Lenient Versus Strict Rate Control II trial as well as to assess the role of digoxin to achieve heart rate targets. Read More
